Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.
Reported out of Assembly Committee, 2nd Reading
Summary
The bill orders a wide range of New Jersey health benefit contracts—including hospital, medical, individual, group, HMO, and state‑run plans—to pay for continuous glucose monitoring systems when a doctor prescribes them for glycogen storage disease. Coverage must be the same as for any other medical condition and applies to contracts issued or renewed after the law takes effect. The goal is to give patients with this rare disorder easier access to essential monitoring technology.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when A 3242 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 3242 freeOr ask your AI assistant about A 3242 directly:
Add to Claude, ChatGPT or Cursor